Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes

PharmacoEconomics
Jinsong GengYingyao Chen

Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of antidiabetic drugs used for treating type 2 diabetes mellitus. While many studies have reported on the cost-effectiveness of DPP-4 inhibitors for treating type 2 diabetes, a systematic review of economic evaluations of DPP-4 inhibitors is currently lacking. The aim of this systematic review was to assess the cost effectiveness of DPP-4 inhibitors for patients with type 2 diabetes. MEDLINE, EMBASE, National Health Service Economic Evaluation Database (NHS EED), Web of Science, EconLit databases, and the Cochrane Library were searched in November 2013. Studies assessing the cost effectiveness of DPP-4 inhibitors for type 2 diabetes were eligible for analysis. DPP-4 inhibitor monotherapy or combinations with other antidiabetic agents were included in the review. The DPP-4 inhibitors were all marketed drugs. Two reviewers independently reviewed titles, abstracts, and articles sequentially to select studies for data abstraction based on the inclusion and exclusion criteria. Disagreements were resolved by consensus. The quality of included studies was assessed according to the 24-item checklist of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) stat...Continue Reading

References

Nov 17, 2004·Health Technology Assessment : HTA·M J SculpherA Eastwood
Jan 19, 2008·Diabetes, Obesity & Metabolism·R ScottUNKNOWN Sitagliptin Study 801 Group
May 23, 2008·Diabetes Research and Clinical Practice·Matteo MonamiEdoardo Mannucci
Sep 5, 2008·PharmacoEconomics·Christopher McCabeAnthony J Culyer
Mar 10, 2009·Diabetes, Obesity & Metabolism·A-M AasUNKNOWN DIGAMI 2 Investigators
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Feb 23, 2010·Diabetes Research and Clinical Practice·Ping ZhangGregory Nichols
Apr 15, 2010·JAMA : the Journal of the American Medical Association·Olivia J PhungCraig I Coleman
May 28, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Susan van DierenBruce Neal
Oct 12, 2010·The New England Journal of Medicine·Sophia ZoungasUNKNOWN ADVANCE Collaborative Group
Oct 5, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Scott KlarenbachEhud Ur
Oct 18, 2011·Primary Care Diabetes·Ola GranströmMartin Henriksson
Jul 26, 2012·Health Economics Review·Antonio J García-RuizMiguel A Casado
Aug 7, 2012·Occupational and Environmental Medicine·Heleen H Hamberg-van ReenenMatthijs van den Berg
Mar 27, 2013·PharmacoEconomics·Don HusereauElizabeth Loder
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Apr 30, 2013·Health Economics Review·Jorge F ElgartJuan J Gagliardino
Nov 5, 2013·Diabetes Research and Clinical Practice·J B McGillS J Fisher
Dec 25, 2013·PloS One·Yazdan YazdanpanahA David Paltiel
Jan 17, 2014·The New England Journal of Medicine·Deirdre K TobiasFrank B Hu
Apr 17, 2014·Diabetes Technology & Therapeutics·Joni L Strom WilliamsLeonard E Egede
Jun 11, 2014·JAMA : the Journal of the American Medical Association·Amisha Wallia, Mark E Molitch
Jun 26, 2014·Early Intervention in Psychiatry·Cathrine Mihalopoulos, Mary Lou Chatterton

❮ Previous
Next ❯

Citations

Apr 15, 2016·Current Diabetes Reports·Vishal Ahuja, Chia-Hung Chou
Oct 19, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Alexandre BaptistaJulian Perelman
Oct 28, 2016·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jason GordonJorge Puelles
Feb 24, 2017·Journal of Managed Care & Specialty Pharmacy·Karen L RascatiDamian Everhart
Apr 19, 2019·The Cochrane Database of Systematic Reviews·Kasper S MadsenBianca Hemmingsen
Apr 14, 2017·Expert Review of Pharmacoeconomics & Outcomes Research·Gustavo Laine Araujo De OliveiraFrancisco de Assis Acurcio
Jul 4, 2020·International Journal of Technology Assessment in Health Care·Sarah FontenayNicolas Martelli
Jan 19, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Corinne EmeryBruno Detournay
Jul 14, 2017·Diabetes & Metabolic Syndrome·Maurílio de Souza CazarimCristina Sanches

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.